Alveolar hypoxia causes pulmonary vasoconstriction; we investigated whether hypoxia could also impair pulmonary vasodilation. We found in the isolated perfused rat lung a delay in vasodilation following agonist-induced vasoconstriction. The delay was not due to erythrocyte or plasma factors, or to alterations in base-line lung perfusion pressure. Pretreating lungs with arachidonic acid abolished hypoxic vasoconstriction, but did not influence the hypoxia-induced impairment of vasodilation after angiotensin II, bradykinin, or serotonin pressor responses. Progressive slowing of vasodilation followed angiotensin II-induced constriction as the lung oxygen tension fell progressively below 60 Torr. KCl, which is not metabolized by the lung, caused vasoconstriction; the subsequent vasodilation time was delayed during hypoxia. However, catecholamine depletion in the lungs abolished this hypoxic vasodilation delay after KCl-induced vasoconstriction. In lungs from high altitude rats, the hypoxia-induced vasodilation impairment after an angiotensin II pressor response was markedly less than it was in lungs from low altitude rats. We conclude from these studies that (a) hypoxia impairs vasodilation of rat lung vessels following constriction induced by angiotensin II, serotonin, bradykinin, or KCl, (b) hypoxia slows vasodilation following KCl-induced vasoconstriction probably by altering lung handling of norepinephrine, (c) the effect of hypoxia on vasodilation is not dependent on its constricting effect on lung vessels, (d) high altitude acclimation moderates the effect of acute hypoxia on vasodilation, and (e) the hypoxic impairment of vasodilation is possibly the result of an altered rate of dissociation of agonists from their membrane receptors on the vascular smooth muscle.
Norbert F. Voelkel, Ivan F. McMurtry, John T. Reeves
Title and authors | Publication | Year |
---|---|---|
The Responses of Pulmonary and Systemic Circulation and Airway to Allergic Mediators in Anesthetized Rats
M Wang, T Shibamoto, Y Kuda, M Tanida, T Zhang, J Song, K Mukai, Y Kurata |
Biological & Pharmaceutical Bulletin | 2016 |
Cerium oxide nanoparticles protect rodent lungs from hypobaric hypoxia-induced oxidative stress and inflammation
A Arya, NK Sethy, SK Singh, M Das, K Bhargava |
International Journal of Nanomedicine | 2013 |
Hypoxic Pulmonary Vasoconstriction
ER Swenson |
High Altitude Medicine & Biology | 2013 |
Hypoxic pulmonary vasoconstriction.
Sylvester JT, Shimoda LA, Aaronson PI, Ward JP |
Physiological reviews | 2012 |
Endothelium-derived mediators and hypoxic pulmonary vasoconstriction
PI Aaronson, TP Robertson, JP Ward |
Respiratory Physiology & Neurobiology | 2002 |
Hypoxia inhibits the Na + /Ca 2+ exchanger in pulmonary artery smooth muscle cells
YO Wang, PK Dhulipala, MI Kotlikoff |
The FASEB Journal | 2000 |
Right ventricular diastolic performance: Compliance characteristics with focus on pulmonary hypertension, right ventricular hypertrophy, and calcium channel blockade
J Ferlinz |
Catheterization and Cardiovascular Diagnosis | 1998 |
Ion Flux in Pulmonary Vascular Control
EK Weir, JR Hume, JT Reeves |
1993 | |
Effect of cyclic guanosine monophosphate on hypoxic and angiotensin-II-induced pulmonary vasoconstriction
K Fujimoto, A Sakai, S Yoshikawa, S Shinozaki, Y Matsuzawa, K Kubo, T Kobayashi, G Ueda, M Sekiguchi, NF Voelkel |
Lung | 1990 |
Dibutyryl cyclic adenosine monophosphate inhibits pulmonary vasoconstriction
A Sakai, NF Voelkel |
Lung | 1988 |
Der Internist
E Buchborn, M Classen, W Dölle, R Gross, J van de Loo, G Riecker, PC Scriba, W Siegenthaler, P von Wichert |
Der Internist | 1988 |
Pressor responses to arachidonic acid in pump-perfused sheep lungs
ML Tod, S Cassin |
Prostaglandins, Leukotrienes and Medicine | 1986 |
Calcium-induced pulmonary vasodilation: modification by meclofenamate and ouabain
NF Voelkel |
Prostaglandins, Leukotrienes and Medicine | 1984 |